Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/21521
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRawiphan Witoonpanichen_US
dc.contributor.authorCharungthai Dejthevapornen_US
dc.contributor.authorTheerayuth Srisinroongruangen_US
dc.contributor.authorWises Subhannacharten_US
dc.contributor.authorSukasom Attanavanichen_US
dc.contributor.authorSomboon Boonkasemen_US
dc.contributor.authorAmmarin Thakkinstianen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherFaculty of Medicine, Ramathibodi Hospital, Mahidol Universityen_US
dc.date.accessioned2018-07-24T03:47:54Z-
dc.date.available2018-07-24T03:47:54Z-
dc.date.issued2004-10-01en_US
dc.identifier.citationJournal of the Medical Association of Thailand. Vol.87, No.10 (2004), 1172-1175en_US
dc.identifier.issn01252208en_US
dc.identifier.other2-s2.0-8444227475en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=8444227475&origin=inwarden_US
dc.identifier.urihttp://repository.li.mahidol.ac.th/dspace/handle/123456789/21521-
dc.description.abstractThymectomy has gained widespread acceptance as a treatment for patients with myasthenia gravis (MG). Patients with myasthenia gravis who had undergone thymectomy by extended transsternal approach between 1981 and 1987 were retrospectively reviewed to evaluate the result of thymectomy, time to remission, time to maximum improvement and factors influencing remission after thymectomy. There were 128 patients, 45 men and 83 women and the mean ages at the time of thymectomy were 35.7 and 32.2 years respectively. After thymectomy, 41.2% of the patients were in remission, 53% improved and 5.8% had no response. The remission rates at 1, 2, 5 and 10 years after thymectomy were 9%, 17%, 37% and 53% respectively and the median time to remission was 9 years. The maximum improvement rates at 1, 2, 5 and 10 years after thymectomy were estimated to be 30%, 40%, 57% and 78% respectively and the median time to maximum improvement was 3.6 years. Patients with ocular MG, longer duration of symptoms before thymectomy and atrophic thymus gland appeared to take longer to achieve remission although none of the factors was significantly associated with the time to remission. Thymectomy is beneficial for MG patients with satisfactory remission and improvement rates. It is recommended that thymectomy should be advocated for these patients early in the course of the disease because the duration of the symptoms appeared to be the main determinant of the outcome.en_US
dc.rightsMahidol Universityen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=8444227475&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleLong-term outcome and factors influencing the outcome of thymectomy for myasthenia gravisen_US
dc.typeReviewen_US
dc.rights.holderSCOPUSen_US
Appears in Collections:Scopus 2001-2005

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.